PCL102H1 Lecture Notes - Lecture 12: T Cell, Viral Load, Manually Coded Language
27 Feb 2019
School
Department
Course
Professor
Document Summary
Lecture 12: patient engagement and clinical trial awareness. Clinical trial case studies: clinical trial for new hiv drug. Transmission of new hiv infections from male-to-male sexual contact (53%) Heterosexual contact = 33%, injection dose 11% and male-to-male sexual contact & injection drug use = 3% What if you become sick: must have 24hr toll free number for trial doctors. You might not be allowed to take certain medicines. For most investigational drugs, the interactions with street drugs is unknown. Signing the consent form is not the end you will receive a copy of the signed form. Investigators have the responsibility to continue to inform you of: any added information about the drug you are taking, any information that would influence your decision to take part in the trial. The investigator needs your consent that you wish to continue to participate. You have the right to leave a clinical trial at any time.
